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NanoBRET displacement assay
NanoBRET displacement assays were performed as previously described [1] . In brief, Nluc-H4R expressing HEK293T cells were incubated with 50 nM clobenpropit-BODIPY (HelloBio, UK) and increasing concentration of unlabeled ligand (10 -5 M to 10 -11 M) in HBSS for 2 h at 25°C. Subsequently, binding of clobenpropit-BODIPY was detected by addition of Nanoglo (Promega, UK) as BRET ratio between Nluc (460 ± 80 nm) and clobenpropit-BODIPY (>610 nm) using a PHERAstar plate reader (BMG, Germany). Synthesis of final compounds 10-12, 20-23, 34-37 and 43 4-Chloro-6-isopropylpyrimidin-2-amine (5). A preparation for this compound was previously published by us [46] . 2-Amino-6-isopropylpyrimidin-4(3H)-one 3 (4.87 g, 31.8 mmol) was dissolved in POCl3 (40 mL, 0.43 mol). The mixture was heated to reflux for 3 h. The solvent was removed under reduced pressure. Ice (150 g) was carefully added to the residue. The pH of the mixture was adjusted to 9-10 with aq. NaOH (2.5 M). The mixture was extracted with DCM (3 x 100 mL). The combined organic phases were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH 10:0 to 9:1) gave the title compound as an off-white solid (1.41 g, 26 %). 1 H NMR (500 MHz, CDCl3) δ 6.53 (s, 1H), 5.33 (br, 2H), 2.77 (hept, J = 6.9 Hz, 1H), 1.22 (d, J = 6.9 Hz, 6H). HPLC-MS (acidic mode): tR = 3.5 min, purity: 96.8 %, [M + H] + : 172. 4-Chloro-6-methylpyrimidin-2-amine (6). 2-Amino-6-methypyrimidin-4(3H)-one 4 (5.00 g, 40.0 mmol) was dissolved in POCl3 (60 mL, 0.64 mol). The mixture was heated to reflux for 3 h. The solvent was removed under reduced pressure. Ice (150 g) was carefully added to the residue. The pH of the mixture was adjusted to 9-10 with aq. NaOH (2.5 M). The mixture was extracted with DCM (3 x 100 mL). The combined organic phases were dried over Na2SO4, filtered and concentrated in vacuo. The residue was recrystallized from EtOH. The title compound was obtained as off-white crystals (1.91 g, 33 %). 1 H NMR (250 MHz, CDCl3) δ 6.54 (s, 1H), 5.32 (br, 2H), 2.32 (s, 3H). HPLC (acidic mode): tR = 2.5 min, purity: >99 %, mass too low to be detectable under used analytical conditions.
Tert-butyl
(1-(2-amino-6-isopropylpyrimidin-4-yl)azetidin-3-yl)(methyl)carbamate (7). A preparation for this compound was previously published by us [46] .A microwave vial charged with chloride 5 (300 mg, 1.75 mmol), tert-butyl azetidin-3-yl(methyl)carbamate hydrochloride (389 mg, 1.75 mmol), DIPEA (0.61 mL, 3.50 mmol) and dioxane (10 mL) was heated for 30 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (20 mL) and extracted with DCM (3 x 15 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH 10:0 to 9:1) gave the title compound as a yellow oil (280 mg, 50 %). 1 H NMR (250 MHz, CDCl3) δ 5.50 (s, 1H), 5.03 (br, 1H), 4.79 (br, 2H), 4.20 (t, J = 8.6 Hz, 2H), 4.07 -3.95 (m, 2H), 2.93 (s, 3H), 2.65 (hept, J = 6.9 Hz, 1H), 1.46 (s, 9H), 1.20 (d, J = 6.9 Hz, 6H). HPLC-MS (acidic mode): tR = 3.4 min, purity: >99 %, [M + H] + : 322.
Tert-butyl 4-(2-amino-6-isopropylpyrimidin-4-yl)piperazine-1-carboxylate (8).
A microwave vial charged with chloride 5 (560 mg, 3.26 mmol), tert-butyl piperazine-1-carboxylate (608 mg, 3.26 mmol), DIPEA (0.57 mL, 3.26 mmol) and dioxane (15 mL) was heated for 30 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (30 mL) and extracted with DCM (3 x 20 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH 10:0 to 9:1) gave the title compound as an off-white solid (1.05 g) which has an LC purity of >99 % but an estimated purity > 90 % by 1 H NMR analysis. 1 H NMR (250 MHz, CDCl3) δ 5.80 (s, 1H), 4.77 (br, 2H), 3.62 -3.53 (m, 4H), 3.52 -3.44 (m, 4H), 2.67 (hept, J = 6.9 Hz, 1H), 1.47 (s, 9H), 1.21 (d, J = 6.9 Hz, 6H). HPLC-MS (acidic mode): tR = 3.8 min, purity: >99 %, [M + H] + : 322.
Tert-butyl 4-(2-amino-6-methylpyrimidin-4-yl)piperazine-1-carboxylate (9).
A microwave vial charged with chloride 6 (1.15 g, 8.00 mmol), tert-butyl piperazine-1-carboxylate (1.49 g, 8.00 mmol), DIPEA (1.40 mL, 8.00 mmol) and dioxane (30 mL) was heated for 30 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (60 mL) and extracted with DCM (3 x 30 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH 20:0 to 19:1) gave the title compound as an off-white solid (2.01 g, 85 %). 1 H NMR (250 MHz, CDCl3) δ 5.82 (s, 1H), 4.76 (br, 2H), 3.62 -3.52 (m, 4H), 3.52 -3.40 (m, 4H), 2.22 (d, J = 0.5 Hz, 3H), 1.47 (s, 9H). HPLC-MS (acidic mode): tR = 3.0 min, purity: >99 %, [M + H] + : 294. 4-(3-(Dimethylamino)azetidin-1-yl)-6-isopropylpyrimidin-2-amine (10). A preparation for this compound was previously published by us [46] . A microwave vial charged with chloride 5 (248 mg, 1.44 mmol), N,N-dimethylazetidin-3-amine dihydrochloride (250 mg, 1.44 mmol), DIPEA (0.76 mL, 4.33 mmol) and dioxane (10 mL) was heated for 30 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (20 mL) and extracted with DCM (3 x 20 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH:TEA 100:0:0 to 90:9:1) gave the title compound as a white solid (220 mg, 65 %). Mp: 123.6-123.8 ℃. 1 H NMR (500 MHz, CDCl3) δ 5.49 (s, 1H), 4.87 (br, 2H), 4.04 (t, J = 7.8 Hz, 2H), 3.94 -3.81 (m, 2H), 3.21 (p, J = 5.6 Hz, 1H), 2.65 (hept, J = 6.8 Hz, 1H), 2.20 (s, 6H), 1.20 (d, J = 6.8 Hz, 6H). 13 
4-(4-Cyclobutylpiperazin-1-yl)-6-isopropylpyrimidin-2-amine (11).
A microwave vial charged with chloride 5 (453 mg, 2.64 mmol), 1-cyclobutylpiperazine (370 mg, 2.64 mmol), DIPEA (0.46 mL, 2.64 mmol) and dioxane (15 mL) was heated for 30 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (30 mL) and extracted with DCM (3 x 25 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH:TEA 100:0:0 to 90:9:1) gave the title compound as a white solid (428 mg, 59 %). Mp: 126.3-126.7 ℃. 1 H NMR (500 MHz, CDCl3) δ 5.81 (s, 1H), 4.77 (br, 2H), 3.60 (t, J = 5.0 Hz, 4H), 2.78 -2.62 (m, 2H), 2.35 (t, J = 5.1 Hz, 4H), 2.09 -2.01 (m, 2H), 1.95 -1.85 (m, 2H), 1.79 -1.63 (m, 2H), 1.21 (d, J = 6.8 Hz, 6H). 13 C NMR (126 MHz, CDCl3) δ 175. 1, 163.6, 162.3, 90.1, 60.3, 49.2, 43.7, 36.0, 27.2, 21.9, 14.4 
4-(4-Cyclobutylpiperazin-1-yl)-6-methylpyrimidin-2-amine (12).
To a solution of carbamate 9 (960 mg, 1.88 mmol) in dioxane (18 mL) was added HCl in dioxane (4N, 8.2 mL, 32.8 mmol). The reaction mixture was stirred for 2 h at rt. The reaction mixture was diluted with satd. aq. Na2CO3 (10 mL) and brine (40 mL) and extracted with DCM (3 x 30 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. The resulting crude 4-methyl-6-(piperazin-1-yl)pyrimidin-2-amine (305 mg) was used for the next step without further purification. To a solution of crude amine intermediate in DCM (8 mL) was added cyclobutanone (140 L, 1.88 mmol). After 10 min of stirring at rt, NaBH(OAc)3 (446 mg, 2.36 mmol) was added and the resulting mixture was stirred at rt overnight. The reaction mixture was quenched with satd. aq. Na2CO3 solution (10 mL) and extracted with DCM (3 x 5 mL). The combined organic phases were dried over Na2SO4, filtered and concentrated in vacuo. The crude product was purified by flash chromatography (DCM:MeOH 10:0 to 9:1). The selected fractions were collected and the solvents were removed under reduced pressure. The residue was triturated with Et2O to give the title compound as a white solid (155 mg (13) . To a solution of amine 7 (500 mg, 1.56 mmol) in DCM (20 mL) was added SbCl3 (710 mg, 3.11 mmol) and tBuONO (0.72 mL, 6.22 mmol). The reaction mixture was stirred for 3 h at rt. Aq. Na2CO3 (1.0 M, 20 mL) was added. The suspension was filtered. The filtrate was extracted with DCM (3 x 10 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH 10:0 to 9:1) gave the title compound as a yellow oil (202 mg, 40 %). 1 Tert-butyl 4-(2-chloro-6-isopropylpyrimidin-4-yl)piperazine-1-carboxylate (14). To a solution of amine 8 (1.10 g, 3.42 mmol) in DCM (40 mL) was added SbCl3 (1.56 g, 6.84 mmol) and tBuONO (1.57 mL, 13.7 mmol). The reaction mixture was stirred for 3 h at rt. Aq. Na2CO3 (1.0 M, 40 mL) was added. The suspension was filtered. The filtrate was extracted with DCM (3 x 20 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated The reaction mixture was stirred for 3 h at rt. The solvent was evaporated. The residue was diluted with aq. Na2CO3 (1.0 M, 10 mL) and extraction with DCM (3 x 8 mL) was performed. The combined organic phases were dried over Na2SO4, filtered and concentrated in vacuo. The resulting crude 1-(2-chloro-6isopropylpyrimidin-4-yl)-N-methylazetidin-3-amine (131 mg) was used for the next step without further purification. To a solution of crude amine intermediate in DCM (5 mL) was added formalin (37 %, 46 L, 0.62 mmol). After 10 min of stirring at rt, NaBH(OAc)3 (220 mg, 1.04 mmol) was added and the resulting mixture was stirred at rt overnight. The reaction mixture was quenched with satd. aq. NaHCO3 (10 mL) and extracted with DCM (3 x 5 mL). The combined organic phases were dried over Na2SO4, filtered and concentrated 
Tert-butyl (1-(2-chloro-6-isopropylpyrimidin-4-yl)azetidin-3-yl)(methyl)carbamate

2-Chloro-4-(4-cyclobutylpiperazin-1-yl)-6-isopropylpyrimidine (17).
To a solution of carbamate 14 (330 mg, 0.97 mmol) in dioxane (5 mL) was added HCl in dioxane (4N, 3.60 mL, 14.4 mmol). The reaction mixture was stirred for 2 h at rt. The solvent was evaporated. The residue was diluted with aq. Na2CO3 (1.0 M, 10 mL) and extracted with DCM (3 x 8 mL). The combined organic phases were dried over Na2SO4, filtered and concentrated in vacuo. The resulting crude 2-chloro-4-isopropyl-6-(piperazine-1-yl)pyrimidin (234 mg) was used for the next step without further purification. To a solution of crude amine intermediate in DCM (10 mL) was added cyclobutanone (85 L, 1.14 mmol). After 10 min of stirring at rt, NaBH(OAc)3 (301 mg, 1.42 mmol) was added and the resulting mixture was stirred at rt overnight. The reaction mixture was quenched with satd. aq. NaHCO3 (20 mL) and extracted with DCM (3 x 10 mL). The combined organic phases were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH 20:0 to 19:1) gave the title compound as a colourless oil (200 mg, 70 % over two steps). 1 H NMR (250 MHz, CDCl3) δ 6.21 (s, 1H), 3.68 (app. s, 4H), 2.91 -2.69 (m, 2H), 2.48 -2.34 (m, 4H), 2.14 -2.00 (m, 2H), 2.00 -1.84 (m, 2H), 1.83 -1.62 (m, 2H), 1.24 (d, J = 6.9 Hz, 6H). HPLC-MS (acidic mode): tR = 3.2 min, purity: >99 %, [M + H] + : 295. -4-(4-cyclobutylpiperazin-1-yl)-6-methylpyrimidine (18) . To a solution of carbamate 15 (490 mg, 1.57 mmol) in dioxane (10 mL) was added HCl in dioxane (4N, 4.50 mL, 18.0 mmol). The reaction mixture was stirred at rt overnight. The solvent was evaporated. The residue was diluted with aq. Na2CO3 (1.0 M, 10 mL) and extracted with DCM (3 x 10 mL). The combined organic phases were dried over Na2SO4, filtered and concentrated in vacuo. The resulting crude 2-chloro-4-methyl-6-(piperazine-1-yl)pyrimidin (232 mg) was used for the next step without further purification. To a solution of crude amine intermediate in DCM (8 mL) was added cyclobutanone (95 L, 1.27 mmol). After 10 min of stirring at rt, NaBH(OAc)3 (336 mg, 1.59 mmol) was added and the resulting mixture was stirred at rt overnight. The reaction mixture was quenched with satd. aq. Na2CO3 (15 mL) and extracted with DCM (3 x 10 mL). The combined organic phases were dried over Na2SO4, filtered and concentrated Cyclobutylpiperazin-1-yl)-6-methyl-2-((trimethylsilyl)ethynyl)pyrimidine (19) . A microwave vial was charged with chloride 18 (72 mg, 0.27 mmol), DME (2 mL), TEA (0.5 mL) and ethynyltrimethylsilane (76 L, 0.54 mmol). The mixture was degassed with N2 for 10 min. Pd(dppf)Cl2 (11 mg, 0.013 mmol) and CuI (5.1 mg, 0.027 mmol) were added. The reaction mixture was heated for 1 h at 100 °C under microwave irradiation. The reaction mixture was diluted with water (10 mL) and extracted with DCM (3 x 8 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. 
2-Chloro
4-(4-
4-(4-Cyclobutylpiperazin-1-yl)-2-ethynyl-6-methylpyrimidine (20).
To a solution of alkyne 19 (48 mg, 0.15 mmol) in MeOH (2 mL) was added K2CO3 (20 mg, 0.15 mmol). The reaction mixture was stirred for 1 h at rt. The solvent was evaporated. The residue was diluted with water (10 mL) and extracted with DCM (3 x 8 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH 98:2 to 94:6) gave the title compound as a colourless oil (27 mg, 72 %). 1 H NMR (500 MHz, CDCl3) δ 6.29 (s, 1H), 3.62 (br, 4H), 2.91 (s, 1H), 2.70 (p, J = 7.9 Hz, 1H), 2.36 -2.32 (m, 4H), 2.31 (s, 3H), 2.07 -1.97 (m, 2H), 1.92 -1.80 (m, 2H), 1.76 -1.59 (m, 2H). 13 C NMR (126 MHz, CDCl3) δ 165.6, 161.9, 150.8, 101.2, 82.8, 73.1, 60.1, 49.0, 43.6, 27.1, 24.3, 14. 1-(6-Isopropyl-2-vinylpyrimidin-4-yl)-N,N-dimethylazetidin-3-amine (21) . To a solution of chloride 16 (105 mg, 0.41 mmol) and vinylboronic acid MIDA ester (75 mg, 0.41 mmol) in DME (2.5 mL) was added Na2CO3 (87 mg, 0.82 mmol) in H2O (0.8 mL). The mixture was degassed with N2 for 10 min and Pd(PPh3)4 (23.8 mg, 0.021 mmol) in DME (0.5 mL) was added. The reaction mixture was heated for 1 h at 120 °C under microwave irradiation. The reaction mixture was diluted with water (20 mL) and extracted with DCM (3 x 15 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH 100:0 to 93:7) gave the title compound as a yellow oil (63 mg, 62 %). 1 H NMR (500 MHz, CDCl3) δ 6.70 (dd, J = 17.2, 10.4 Hz, 1H), 6.49 (dd, J = 17.2, 2.2 Hz, 1H), 5.90 (s, 1H), 5.56 (dd, J = 10.4, 2.2 Hz, 1H), 4.10 (t, J = 7.8 Hz, 2H), 3.90 (dd, J = 8.3, 5.4 Hz, 2H), 3.29 -3.19 (m, 1H), 2.81 (hept, J = 6.9 Hz, 1H), 2.21 (s, 6H), 1.23 (d, J = 6.9 Hz, 6H). 13 C NMR (126 MHz, CDCl3) δ 173.8, 163.8, 163.2, 137.6, 122.3, 96.2, 56.6, 54.1, 42.0, 35.9, 22. Cyclobutylpiperazin-1-yl)-6-isopropyl-2-vinylpyrimidine (22) . To a solution of chloride 17 (195 mg, 0.66 mmol) and vinylboronic acid MIDA ester (121 mg, 0.66 mmol) in DME (4 mL) was added Na2CO3 (140 mg, 1.32 mmol) in H2O (1 mL). The mixture was degassed with N2 for 10 min and Pd(PPh3)4 (76 mg, 0.066 mmol) was added. The reaction mixture was heated for 30 min at 120 °C under microwave irradiation. The reaction mixture was diluted with water (20 mL) and extracted with DCM (3 x 15 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH 20:0 to 19:1) gave the title compound as a yellow oil (40 mg, 21 %). 1 H NMR (500 MHz, CDCl3) δ 6.71 (dd, J = 17.2, 10.4 Hz, 1H), 6.49 (dd, J = 17.2, 2.2 Hz, 1H), 6.21 (s, 1H), 5.57 (dd, J = 10.4, 2.2 Hz, 1H), 3.79 -3.60 (m, 4H), 2.90 -2.70 (m, 2H), 2.48 -2.34 (m, 4H), 2.13 -2.01 (m, 2H), 2.00 -1.87 (m, 2H), 1.80 -1.65 (m, 2H), 1.25 (d, J = 6.9 Hz, 6H). 13 C NMR (126 MHz, CDCl3) δ 174.7, 163.1, 162.6, 137.8, 122.2, 96.9, 60.3, 49.2, 43.6, 36.2, 27.1, 22.1, 14.4 
4-(4-
4-(4-Cyclobutylpiperazin-1-yl)-6-methyl-2-vinylpyrimidine (23).
To a solution of chloride 18 (80 mg, 0.30 mmol) and vinylboronic acid MIDA ester (58 mg, 0.32 mmol) in DME (1.6 mL) was added Na2CO3 (64 mg, 0.60 mmol) in H2O (0.4 mL). The mixture was degassed with N2 for 10 min and Pd(PPh3)4 (35 mg, 0.030 mmol) was added. The reaction mixture was heated for 1 h at 120 °C under microwave irradiation. The reaction mixture was diluted with water (10 mL) and extracted with DCM (3 x 8 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH 100:0 to 94:6) gave the title compound as a yellow oil (20 mg, 26 %). 1 H NMR (500 MHz, CDCl3) δ 6.69 (dd, J = 17.3, 10.4 Hz, 1H), 6.48 (dd, J = 17.3, 2.1 Hz, 1H), 6.23 (s, 1H), 5.58 (dd, J = 10.4, 2.1 Hz, 1H), 3.68 (t, J = 5.2 Hz, 4H), 2.74 (p, J = 8.0 Hz, 1H), 2.43 -2.37 (m, 4H), 2.36 (s, 3H), 2.11 -2.01 (m, 2H), 1.97 -1.86 (m, 2H), 1.79 -1.64 (m, 2H). 13 C NMR (126 MHz, CDCl3) δ 165.5, 163.2, 162.3, 137.5, 122.4, 99.9, 60.3, 49.2, 43.5, 27.2, 24.5, 14.4 . HPLC-MS basic mode): tR = 4.5 min, purity: 96.9 %, [M + H] + : 259. HR-MS [M + H] + calcd for C15H23N4 + : 259.1917, found 259.1919 .
6-Isopropyl-2-methylpyrimidin-4(3H)-one (26).
To an ice-cold solution of acetamidine hydrochloride 24 (2.08 g, 22.0 mmol) and methyl 4-methyl-3-oxopentanoate (2.88 g, 20.0 mmol) in MeOH (25 mL) was added NaOMe (3.24 g, 60.0 mmol) in portions. The reaction mixture was stirred at rt overnight. The reaction mixture was concentrated to half the volume and diluted with water (50 mL). The pH of the filtrate was adjusted to 4 with aq. HCl (3.0 M). The mixture was extracted with DCM (3 x 40 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH 10:0 to 9:1) gave the title compound as a white solid (2.77 g, 91 %). 1 H NMR (500 MHz, CDCl3) δ 13.36 (br, 1H), 6.18 (s, 1H), 2.75 (hept, J = 6.8 Hz, 1H), 2.47 (s, 3H), 1.22 (d, J = 6.9 Hz, 6H). HPLC-MS (acidic mode): tR = 1.9 min, purity: >99 %, [M + H] + : 153.
2-Ethyl-6-isopropylpyrimidin-4(3H)-one (27).
To an ice-cold solution of propionamidine hydrochloride 25 (1.00 g, 9.21 mmol) and methyl 4-methyl-3-oxopentanoate (1.21 g, 8.37 mmol) in MeOH (10 mL) was added NaOMe (1.36 g, 25.1 mmol) in portions. The reaction mixture was stirred at rt overnight.
The reaction mixture was concentrated to half the volume and diluted with water (20 mL). The pH of the filtrate was adjusted to 4 with aq. HCl (3.0 M). The mixture was extracted with DCM (3 x 20 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH 10:0 to 9:1) gave the title compound as a white solid (1.35 g, 97 %). 1 H NMR (500 MHz, CDCl3) δ 13.28 (s, 1H), 6.18 (s, 1H), 2.88 -2.61 (m, 3H), 1.33 (t, J = 7.6 Hz, 3H), 1.21 (d, J = 6.9 Hz, 6H). HPLC-MS (acidic mode): tR = 1.9 min, purity: >99 %, [M + H] + : 167. Chloro-6-isopropyl-2-methylpyrimidine (28) . Pyrimidin-4(3H)-one 26 (2.76 g, 18.1 mmol) was dissolved in POCl3 (30 mL, 0.32 mol). The mixture was heated to reflux for 3 h. The solvent was removed under reduced pressure. Ice (60 g) was carefully added to the residue. The pH of the mixture was adjusted to 9-10 with aq. NaOH (2.5 M). The mixture was extracted with DCM (3 x 60 mL). The combined organic phases were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH 20:0 to 19:1) gave the title compound as a yellow oil (2.70 g, 87 %). 1 H NMR (500 MHz, CDCl3) δ 7.03 (s, 1H), 2.95 (hept, J = 6.9 Hz, 1H), 2.68 (s, 3H), 1.28 (d, J = 6.9 Hz, 6H). HPLC-MS (acidic mode): tR = 4.1 min, purity: >99 %, [M + H] + : 171.
4-
4-Chloro-2-ethyl-6-isopropylpyrimidine (29).
Pyrimidin-4(3H)-one 27 (1.34 g, 8.06 mmol) was dissolved in POCl3 (10 mL, 107 mmol). The mixture was heated to reflux for 3 h. The solvent was removed under reduced pressure. Ice (30 g) was carefully added to the residue. The pH of the mixture was adjusted to 9-10 with aq. NaOH (2.5 M). The mixture was extracted with DCM (3 x 20 mL). The combined organic phases were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH 20:0 to 19:1) gave the title compound as a yellow oil (1.27 g, 86 %). 1 H NMR (500 MHz, CDCl3) δ 7.03 (s, 1H), 3.07 -2.85 (m, 3H), 1.34 (t, J = 7.6 Hz, 3H), 1.29 (d, J = 6.9 Hz, 6H). HPLC-MS (acidic mode): tR = 5.0 min, purity: >99 %, [M + H] + : 185.
Tert-butyl
(1-(6-isopropyl-2-methylpyrimidin-4-yl)azetidin-3-yl)(methyl)carbamate (30). A microwave vial charged with chloride 28 (853 mg, 5.00 mmol), tert-butyl azetidin-3-yl(methyl)carbamate hydrochloride (1.11 g, 5.00 mmol), DIPEA (1.75 mL, 10.0 mmol) and dioxane (30 mL) was heated for 30 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (60 mL) and extracted with DCM (3 x 40 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH 10:0 to 9:1) gave the title compound as an offwhite solid (602 mg, 38 %). 1 H NMR (250 MHz, CDCl3) δ 5.87 (s, 1H), 5.04 (br, 1H), 4.26 (t, J = 8.7 Hz, 2H), 4.06 (dd, J = 9.4, 5.7 Hz, 2H), 2.94 (s, 3H), 2.81 (hept, J = 7.0 Hz, 1H), 2.51 (s, 3H), 1.47 (s, 9H), 1.23 (d, J = 6.9 Hz, 6H). HPLC-MS (acidic mode): tR = 3.2 min, purity: >99 %, [M + H] + : 321.
(1-(2-ethyl-6-isopropylpyrimidin-4-yl)azetidin-3-yl)(methyl)carbamate (31). A microwave vial charged with chloride 29 (739 mg, 4.00 mmol), tert-butyl azetidin-3-yl(methyl)carbamate hydrochloride (891 mg, 4.00 mmol), DIPEA (1.40 mL, 8.00 mmol) and dioxane (20 mL) was heated for 30 min at 150 °C under microwave irradiation. The reaction mixture was diluted with water (40 mL) and extracted with DCM (3 x 30 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography (DCM:MeOH 10:0 to 9:1) gave the title compound as a colourless oil (460 mg, 34 %). 1 H NMR (250 MHz, CDCl3) δ 5.87 (s, 1H), 5.03 (br, 1H), 4.26 (t, J = 8.7 Hz, 2H), 4.07 (dd, J = 9.4, 5.8 Hz, 2H), 2.94 (s, 3H), 2.90 -2.68 (m, 3H), 1.46 (s, 9H), 1.28 (t, J = 7.6 Hz, 3H), 1.23 (d, J = 6.9 Hz, 6H)). HPLC-MS (acidic mode): tR = 4.3 min, purity: >99 %, [M + H] + : 335.
1-(6-Isopropyl-2-methylpyrimidin-4-yl)-N-methylazetidin-3-amine (32).
To a solution of carboxylate 30 (590 mg, 1.84 mmol) in dioxane (10 mL) was added HCl in dioxane (4N, 4.60 mL, 18.4 mmol). The reaction mixture was stirred for 3 h at rt. The solvent was removed under reduced pressure. The residue 
